Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Forte Biosciences Inc.

    NASDAQ: FBRX · Real-Time Price · USD
    11.35
    0.76 (7.18%)
    At close: Jun 26, 2025, 3:59 PM
    10.79
    -4.93%
    After-hours: Jun 26, 2025, 06:09 PM EDT

    Forte Biosciences Statistics

    Share Statistics

    Forte Biosciences has 6.58M shares outstanding. The number of shares has increased by -82.46% in one year.

    Shares Outstanding

    n/a
    		 6.58M

    Shares Change (YoY)

    n/a
    		 -82.46%

    Shares Change (QoQ)

    n/a
    		 337.32%

    Owned by Institutions (%)

    n/a
    		 41.38%

    Shares Floating

    n/a
    		 5.33M

    Failed to Deliver (FTD) Shares

    n/a
    		 1,783

    FTD / Avg. Volume

    n/a
    		 2.37%

    Short Selling Information

    The latest short interest is 173.27K, so 2.63% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 173.27K

    Short % of Shares Out

    n/a
    		 2.63%

    Short % of Float

    n/a
    		 3.74%

    Short Ratio (days to cover)

    n/a
    		 1.55

    Valuation Ratios

    The PE ratio is -1.87 and the forward PE ratio is -2.99. Forte Biosciences's PEG ratio is 0.04.

    PE Ratio

    n/a
    		 -1.87

    Forward PE

    n/a
    		 -2.99

    PS Ratio

    n/a
    		 0

    Forward PS

    n/a
    		 0.6

    PB Ratio

    n/a
    		 1.26

    P/FCF Ratio

    n/a
    		 -2.15

    PEG Ratio

    n/a
    		 0.04
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Forte Biosciences.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 6.76, with a Debt / Equity ratio of 0.

    Current Ratio

    n/a
    		 6.76

    Quick Ratio

    n/a
    		 6.76

    Debt / Equity

    n/a
    		 0

    Debt / EBITDA

    n/a
    		 n/a

    Debt / FCF

    n/a
    		 n/a

    Interest Coverage

    n/a
    		 0

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 n/a

    Profits Per Employee

    n/a
    		 $-2,534,142.86

    Employee Count

    n/a
    		 14

    Asset Turnover

    n/a
    		 0

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 n/a

    Effective Tax Rate

    n/a
    		 0%

    Stock Price Statistics

    The stock price has increased by -17.15% in the last 52 weeks. The beta is 2.86, so Forte Biosciences's price volatility has been higher than the market average.

    Beta

    n/a
    		 2.86

    52-Week Price Change

    n/a
    		 -17.15%

    50-Day Moving Average

    n/a
    		 8.96

    200-Day Moving Average

    n/a
    		 10.43

    Relative Strength Index (RSI)

    n/a
    		 51.53

    Average Volume (20 Days)

    n/a
    		 75,227

    Income Statement

    Revenue

    n/a
    		 n/a

    Gross Profit

    n/a
    		 n/a

    Operating Income

    n/a
    		 -36.6M

    Net Income

    n/a
    		 -35.48M

    EBITDA

    n/a
    		 -35.44M

    EBIT

    n/a
    		 -35.48M

    Earnings Per Share (EPS)

    n/a
    		 -12.17
    Full Income Statement

    Balance Sheet

    The company has 22.24M in cash and 0 in debt, giving a net cash position of 22.24M.

    Cash & Cash Equivalents

    n/a
    		 22.24M

    Total Debt

    n/a
    		 n/a

    Net Cash

    n/a
    		 n/a

    Retained Earnings

    n/a
    		 -154M

    Total Assets

    n/a
    		 47.46M

    Working Capital

    n/a
    		 38.13M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -30.75M and capital expenditures -37K, giving a free cash flow of -30.78M.

    Operating Cash Flow

    n/a
    		 -30.75M

    Capital Expenditures

    n/a
    		 -37K

    Free Cash Flow

    n/a
    		 -30.78M

    FCF Per Share

    n/a
    		 -10.56
    Full Cash Flow Statement

    Margins

    Gross Margin

    n/a
    		 n/a

    Operating Margin

    n/a
    		 n/a

    Pretax Margin

    n/a
    		 n/a

    Profit Margin

    n/a
    		 n/a

    EBITDA Margin

    n/a
    		 n/a

    EBIT Margin

    n/a
    		 n/a

    FCF Margin

    n/a
    		 n/a

    Dividends & Yields

    FBRX does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for FBRX is $61, which is 437.4% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $61

    Price Target Difference

    n/a
    		 437.4%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 2
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Stock Splits

    The last stock split was on Aug 28, 2024. It was a backward split with a ratio of 1:25.

    Last Split Date

    n/a
    		 Aug 28, 2024

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 1:25

    Scores

    Altman Z-Score

    n/a
    		 -2.94

    Piotroski F-Score

    n/a
    		 1

    Add to Watchlist